{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:05:34Z","timestamp":1791129934128,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T00:00:00Z","timestamp":1389830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085113","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T16:22:29Z","timestamp":1389889349000},"page":"e85113","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Reversal Effect of ST6GAL 1 on Multidrug Resistance in Human Leukemia by Regulating the PI3K\/Akt Pathway and the Expression of P-gp and MRP1"],"prefix":"10.1371","volume":"9","author":[{"given":"Hongye","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keji","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,16]]},"reference":[{"key":"ref1","first-page":"187","article-title":"The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway","volume":"67","author":"H Wang","year":"2012","journal-title":"Pharmazie"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2004.10.012","article-title":"Multidrug resistance proteins: role of P-glycoprotein MRP1, MRP2, and BCRP (ABCG2) in tissue defense","volume":"204","author":"EM Leslie","year":"2005","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/978-1-59745-205-2_5","article-title":"Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy","volume":"448","author":"TM Bosch","year":"2008","journal-title":"Methods in Molecular Biology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"S Gergely","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1532\/IJH97.E0624","article-title":"Expression of multidrug resistance 1 (mdr1), multidrug resistance-related protein 1 (mrp1), lung resistance protein (lrp), and breast cancer resistance protein (bcrp) genes and clinical outcome in childhood acute lymphoblastic leukemia","volume":"86","author":"M Kourti","year":"2007","journal-title":"Int J Hematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"M111.009001","DOI":"10.1074\/mcp.M111.009001","article-title":"Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells","volume":"10","author":"M Nakano","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.biocel.2012.04.026","article-title":"Glycomic alterations are associated with multidrug resistance in human leukemia","volume":"44","author":"Z Zhang","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/labinvest.3700656","article-title":"Diversity in cell surface sialic acid presentations: implications for biology and disease","volume":"87","author":"NM Varki","year":"2007","journal-title":"Lab Invest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/0008-5472.CAN-07-1340","article-title":"\u03b12, 6\u2013linked sialic acids on N-Glycans modulate carcinoma differentiation in vivo","volume":"68","author":"M Hedlund","year":"2008","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12038-012-9194-6","article-title":"Characterization of P1 promoter activity of the beta-galactoside alpha2,6-sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines","volume":"37","author":"L Milflores-Flores","year":"2012","journal-title":"J Biosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"22982","DOI":"10.1074\/jbc.M110.211375","article-title":"Sialylation of the fas death receptor by ST6Gal-I provides protection against fas-mediated apoptosis in colon carcinoma cells","volume":"286","author":"AF Swindall","year":"2011","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1158\/0008-5472.CAN-12-3424","article-title":"ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines","volume":"73","author":"AF Swindall","year":"2013","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000072339","article-title":"Clinical relevance of sialyltransferases ST6GAL-I and ST3GAL-III in gastric cancer","volume":"65","author":"S Gretschel","year":"2003","journal-title":"Oncology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1757-2215-6-25","article-title":"ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells","volume":"6","author":"M Schultz","year":"2013","journal-title":"J Ovarian Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e65218","DOI":"10.1371\/journal.pone.0065218","article-title":"Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes","volume":"8","author":"Z Zhang","year":"2013","journal-title":"Plos one"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/glycob\/11.5.407","article-title":"Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation","volume":"11","author":"M Dalziel","year":"2001","journal-title":"Glycobiology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"38399","DOI":"10.1074\/jbc.M110.163931","article-title":"Molecular phylogeny and functional genomics of \u03b2-Galactoside \u03b12, 6-Sialyltransferases that explain ubiquitous expression of ST6GAL1 gene in amniotes","volume":"285","author":"D Petit","year":"2010","journal-title":"J Biol Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/jb\/mvg142","article-title":"Comparison of the enzymatic properties of mouse beta-galactoside alpha2, 6-sialyltransferases, ST6GalI and II","volume":"134","author":"S Takashima","year":"2003","journal-title":"J Biochem (Tokyo)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"45719","DOI":"10.1074\/jbc.M206808200","article-title":"Characterization of the second type of human \u03b2-galactoside \u03b1 2,6-sialyltransferase(ST6Gal II), which sialylates Gal \u03b2 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes","volume":"277","author":"S Takashima","year":"2002","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0065-230X(05)94002-5","article-title":"Activation of AKT kinases in cancer: implications for therapeutic targeting","volume":"94","author":"A Bellacosa","year":"2005","journal-title":"Adv Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.leukres.2008.06.010","article-title":"PI3K\/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines","volume":"33","author":"MG Garcia","year":"2009","journal-title":"Leukemia Research"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/ijc.23122","article-title":"Hyaluronan oligosaccharides sensitize lymphoma resistant cell lines to vincristine by modulating P-glycoprotein activity and PI3K\/Akt pathway","volume":"122","author":"RRI Cordo","year":"2008","journal-title":"Int J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/pbc.24034","article-title":"Activation of Akt is associated with poor prognosis and chemotherapeutic resistance in pediatric B-pecursor acute lymphoblastic leukemia","volume":"59","author":"N Morishita","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11596-009-0412-x","article-title":"LY294002 inhibits K562 leukemic cells by regulating PI3k\/Akt channel <italic>in vitro<\/italic>","volume":"29","author":"Q Wu","year":"2009","journal-title":"Journal of Huazhong Univercity of Science and Technology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejps.2006.08.006","article-title":"LY294,002, a specific inhibitor of PI3K\/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance","volume":"29","author":"M Barancik","year":"2006","journal-title":"European journal of pharmaceutical sciences"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2404523","article-title":"Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts","volume":"21","author":"PL Tazzari","year":"2007","journal-title":"Leukemia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1600-0609.2010.01416.x","article-title":"Involvement of ERK1\/2, p38 and PI3K in megakaryocytic differentiation of K562 cells","volume":"84","author":"I Conde","year":"2010","journal-title":"European Journal of Haematology"},{"key":"ref28","first-page":"4031","article-title":"In vitro evaluation of zoledronic acid resistance developed in MCF-7 cells","volume":"27","author":"MD Kars","year":"2007","journal-title":"Anticancer Reasearch"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.leukres.2009.11.004","article-title":"Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines","volume":"34","author":"SM Daiane","year":"2010","journal-title":"Leukemia Research"},{"key":"ref30","article-title":"\u03b12,3-sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues","author":"M P\u00e9rez-Garay","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12032-010-9771-1","article-title":"Altered mRNA expressions of sialyltransferases in human gastric cancer tissues","volume":"29","author":"J Li","year":"2012","journal-title":"Med Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08021","article-title":"Genes that mediate breast cancer metastasis to the brain","volume":"459","author":"PD Bos","year":"2009","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1471-2407-9-357","article-title":"ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines","volume":"9","author":"M Correia","year":"2009","journal-title":"BMC Cancer"},{"key":"ref34","first-page":"53","article-title":"Sialoglycoconjugate expression in primary colorectal cancer and metastatic lymph node tissues","volume":"54","author":"Y Inagaki","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10555-012-9359-7","article-title":"Regulation of the metastatic cell phenotype by sialylated glycans","volume":"31","author":"MJ Schultz","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1111\/j.1432-1033.2004.04284.x","article-title":"Ras oncogene induces \u03b2 -galactoside \u03b1 2, 6-sialyltransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter","volume":"271","author":"M Dalziel","year":"2004","journal-title":"Eur J Biochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00432-011-1016-y","article-title":"Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation","volume":"137","author":"Y Baran","year":"2011","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.7314\/APJCP.2013.14.4.2201","article-title":"Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K\/Akt\/mTOR and Wnt Pathways","volume":"14","author":"AK Pandurangan","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.3390\/ijms14048213","article-title":"The importance of the PI3K\/AKT\/MTOR pathway in the progression of ovarian cancer","volume":"14","author":"ZC Dobbin","year":"2013","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.onc.1209201","article-title":"The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1","volume":"25","author":"R Abdul-Ghani","year":"2006","journal-title":"Oncogene"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","article-title":"Survival of acute myeloid leukemia cells requires PI3 kinase activation","volume":"102","author":"Q Xu","year":"2003","journal-title":"Blood"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.leu.2403220","article-title":"Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias","volume":"18","author":"S Zhao","year":"2004","journal-title":"Leukemia"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.leu.2403653","article-title":"PI3-kinase\/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways","volume":"19","author":"VL Grandage","year":"2005","journal-title":"Leukemia"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.leu.2404203","article-title":"Activation of FGFR1b signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells","volume":"20","author":"MA Karajannis","year":"2006","journal-title":"Leukemia"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.leu.2404204","article-title":"The role of the nuclear Akt activation and Akt inhibitors in all-trans-retinoic acid-differentiated HL-60 cells","volume":"20","author":"K Matkovic","year":"2006","journal-title":"Leukemia"},{"key":"ref46","first-page":"427","article-title":"Reverse-phase protein microarrays (RPPA) as a diagnostic and therapeutic guide in multidrug resistant leukemia","volume":"38","author":"T Maraldi","year":"2011","journal-title":"Int J Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2404523","article-title":"Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase\/Akt signal transduction network in human acute myelogenous leukemia blasts","volume":"21","author":"PL Tazzari","year":"2007","journal-title":"Leukemia"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nature05630","article-title":"Multiple molecular mechanisms for multidrug resistance transporters","volume":"446","author":"CF Higgins","year":"2007","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0224304","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000},"record-id":"21443"},{"DOI":"10.1371\/journal.pone.0224304","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T00:00:00Z","timestamp":1571270400000}}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T14:23:52Z","timestamp":1565101432000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085113"}},"subtitle":[],"editor":[{"given":"Arun","family":"Rishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085113","relation":{"retraction":[{"id-type":"doi","id":"10.1371\/journal.pone.0224304","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}